Deep Vein Thrombosis Market Size, Share, Development By 2033

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Deep Vein Thrombosis Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The deep vein thrombosis market size has grown steadily in recent years. It will grow from $1.03 billion in 2023 to $1.07 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to increased vascular medicine specialization, influence of medical guidelines, focus on thrombosis prevention, clinical research development, increased diagnosis awareness.

The deep vein thrombosis market size is expected to see steady growth in the next few years. It will grow to $1.26 billion in 2028 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to growing aging population, rising incidence of lifestyle diseases, preventive healthcare emphasis, innovative therapies, focus on patient-centric care. Major trends in the forecast period include risk factors awareness, advancements in diagnosis, treatment innovations, public health initiatives, post-surgical prevention.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=10616&type=smp

Market Segmentation:
The deep vein thrombosis market covered in this report is segmented -
1) By Drug Class: Anticoagulants, Inferior Vena Cava Filters, Other Drug Class
2) By Treatment: Surgery, Drugs, Other Treatments
3) By Mode Of Administration: Injectable, Oral, Other Modes Of Action
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-users

Major Driver - Rising Demand For Deep Vein Thrombosis (DVT) Treatment Drives Market Growth
The increasing number of individuals who require deep vein thrombosis (DVT) treatment is expected to propel the growth of the deep vein thrombosis market going forward. DVT treatment refers to treating patients with deep vein thrombosis using drugs such as anticoagulants and others that prevent the formation of new blood clots and existing blood clots from getting larger, alleviating the disease condition. The increase in the number of patients requiring DVT treatment indicates an increase in the prevalence of deep vein thrombosis that requires products for DVT diagnosis, prevention, and treatment. For instance, in February 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, an overall 900,000 people could be affected each year in the United States due to deep vein thrombosis, and between 60,000 and 100,000 Americans die each year from DVT or PE (pulmonary embolism). Therefore, the increasing number of individuals requiring deep vein thrombosis (DVT) treatment is driving the market.

Competitive Landscape:
Major companies operating in the deep vein thrombosis market report are Abbott Laboratories, Bristol-Myers Squibb Company, Sanofi-Aventis U.S. LLC, Daiichi Sankyo Company Limited, Aspen Pharmacare Holdings Limited, Novartis AG, Mylan N.V., Bayer AG, Boehringer Ingelheim GmbH, Medtronic PLC, Momenta Pharmaceuticals Inc., Hikma Pharmaceuticals PLC, Laboratorios Farmacéuticos Rovi S.A., Cardinal Health Inc., Altimed Ltd., Teva Pharmaceutical Industries Ltd., Swiss Pharma Private Limited, Laurus Labs Limited, AstraZeneca PLC, Stryker Corporation, Cook Medical Incorporated, Boston Scientific Corporation, Koninklijke Philips N.V., Arjo AB, DJO Global Inc., Zimmer Biomet Holdings Inc., Devon Medical Products LLC, ThermoTek USA Inc., Lonza Group AG, Pfizer Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report

Top Trend - Companies Unveil Revolutionary Mechanical Thrombectomy System With Lightning Flash Technology To Driving Innovations In Deep Vein Thrombosis Market
Product innovations are a key trend gaining popularity in the deep vein thrombosis market. Major companies operating in the deep vein thrombosis market are adopting new technologies to develop new product and to sustain their position in the market. For instance, in January 2023, Penumbra Inc., a US-based developer of innovative therapies, launched Lightning Flash, an advanced and powerful mechanical thrombectomy system for addressing venous and pulmonary thrombus. The system features Penumbra's novel lightning-intelligent aspiration technology and innovative dual clot detection algorithms. It is designed to quickly remove large blood clots in the body, including venous thrombus and pulmonary emboli (PE). It provides physicians with a high torque-able, larger catheter designed for efficiently removing a significant clot burden in the pulmonary arteries or deep venous system while maintaining an excellent safety profile.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Deep Vein Thrombosis Market Characteristics
3. Deep Vein Thrombosis Market Trends And Strategies
4. Deep Vein Thrombosis Market - Macro Economic Scenario
5. Deep Vein Thrombosis Market Size And Growth
…..
27. Deep Vein Thrombosis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

This release was published on openPR.